Uncategorized

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – April 11, 2024

Mirum Pharmaceuticals, Inc. announced that on April 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 36,100 shares of common stock and 18,050 restricted stock units to nine new employees under Mirum’s 2020 Inducement Plan.

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – April 11, 2024 Read More »

Scroll to Top